A trial to see the effects of increased doses of ACP-196 (the test drug) in subjects with Leukemia

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-000440-15

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• Establish the safety and the MTD of orally administered acalabrutinib in subjects with CLL/SLL • Determine the PK of orally administered acalabrutinib and identification of its major metabolite


Critère d'inclusion

  • • Chronic Lymphocytic Leukemia
  • • Richter's Syndrome
  • • Prolymphocytic Leukemia